Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia

Blood

Volumn 118, Issue 10, 2011, Pages 2793-2800

  Liao, Aijun ^a,b   Broeg, Kathleen ^a   Fox, Todd ^a,c   Tan, Su Fern ^a   Watters, Rebecca ^a   Shah, Mithun Vinod ^a   Zhang, Lucy Q ^a   Li, Yongping ^a   Ryland, Lindsay ^a,c   Yang, Jun ^a   Aliaga, Cesar ^a   Dewey, Alden ^a   Rogers, Andrew ^a   Loughran, Kelly ^a   Hirsch, Leah ^a   Jarbadan, Nancy Ruth ^a   Baab, Kendall Thomas ^a   Liao, Jason ^a   Wang, Hong Gang ^a,c   Kester, Mark ^a,c   Desai, Dhimant ^a,c   Amin, Shantu ^a,c   Loughran Jr , Thomas P ^a   Liu, Xin ^a   more..

^a PENN STATE CANCER INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; PROTEIN MCL 1; REACTIVE OXYGEN METABOLITE; SPHINGOLIPID;

AGGRESSIVE NK CELL LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IN VITRO STUDY; LEUKEMIA CELL; LEUKEMIA REMISSION; LIPIDOMICS; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 80052653011     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-331447     Document Type: Article

References (37)

1. Lim MS, De Leval L, Quintanilla-Martinez L. Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms. J Hematop. 2009;2:75-76.
2. Lamy T, Loughran TP. Large granular lymphocyte leukemia. Cancer Control. 1998;5(1):25-33. (Pubitemid 28126210)
3. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11(3):263-273.
4. Cheung MM, Chan JK, Wong KF. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol. 2003;40(3):221-232. (Pubitemid 36842600)
5. Gold R. Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved. CNS Drugs. 2011;25(1):37-52.
6. Neviani P, Santhanam R, Oaks JJ, et al. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest. 2007;117(9):2408-2421. (Pubitemid 47494343)
7. Liu Q, Zhao X, Frissora F, et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood. 2008;111(1):275-284.
8. Hinterding K, Albert R, Cottens S. First asymmetric synthesis of chiral analogues of the novel immunosuppressant FTY720. Tetrahedron Letters. 2002;43:8095-8097. (Pubitemid 35232421)
9. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood. 1998;92(12):4771-4777. (Pubitemid 29005880)
10. Epling-Burnette PK, Bai F, Wei S, et al. ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene. 2004;23(57):9220-9229. (Pubitemid 40069692)
11. Fox TE, Bewley MC, Unrath KA, et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res. 2011;52(3):509-517.
12. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917.
13. Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107(3):351-362.
14. Lee WJ, Yoo HS, Suh PG, Oh S, Lim JS, Lee YM. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. Exp Mol Med. 2004;36(5):420-427. (Pubitemid 39556418)
15. Reynolds CW, Bere EW Jr, Ward JM. Natural killer activity in the rat. III. Characterization of transplantable large granular lymphocyte (LGL) leukemias in the F344 rat. J Immunol. 1984;132(1):534-540. (Pubitemid 14210941)
16. Thomas J, Haseman JK, Goodman JI, Ward JM, Loughran TP Jr, Spencer PJ. A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessment. Toxicol Sci. 2007;99(1):3-19. (Pubitemid 47250361)
17. Liu X, Ryland L, Yang J, et al. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood. 2010;116(20):4192-4201.
18. Nijhawan D, Fang M, Traer E, et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 2003;17(12):1475-1486. (Pubitemid 36734705)
19. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290(5497):1717-1721. (Pubitemid 32004796)
20. Guicciardi ME, Deussing J, Miyoshi H, et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest. 2000;106(9):1127-1137.
21. Zhang H, Zhong C, Shi L, Guo Y, Fan Z. Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to necroptosis. J Immunol. 2009;182(11):6993-7000.
22. Droga-Mazovec G, Bojic L, Petelin A, et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem. 2008;283(27):19140-19150.
23. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004;6(5):443-450. (Pubitemid 38607505)
24. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007;26(9):1324-1337. (Pubitemid 46328466)
25. Blomgran R, Zheng L, Stendahl O. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol. 2007;81(5):1213-1223. (Pubitemid 46702040)
26. Brunk UT, Dalen H, Roberg K, Hellquist HB. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med. 1997;23(4):616-626. (Pubitemid 27287345)
27. Hung JH, Lu YS, Wang YC, et al. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res. 2008;68(4):1204-1212.
28. Sabourdy F, Kedjouar B, Sorli SC, et al. Functions of sphingolipid metabolism in mammals-lessons from genetic defects. Biochim Biophys Acta. 2008;1781(4):145-183.
29. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604-616. (Pubitemid 39025055)
30. Pi X, Tan SY, Hayes M, et al. Sphingosine kinase 1-mediated inhibition of Fas death signaling in rheumatoid arthritis B lymphoblastoid cells. Arthritis Rheum. 2006;54(3):754-764.
31. Bektas M, Jolly PS, Muller C, Eberle J, Spiegel S, Geilen CC. Sphingosine kinase activity counter-acts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene. 2005;24(1):178-187. (Pubitemid 40143877)
32. Tonelli F, Lim KG, Loveridge C, et al. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells. Cell Signal. 2010;22(10):1536-1542.
33. Hung WC, Chang HC, Chuang LY. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem J. 1999;338(Pt 1):161-166.
34. Jarvis WD, Fornari FA Jr, Auer KL, et al. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol. 1997;52(6):935-947. (Pubitemid 28013711)
35. Frasch SC, Nick JA, Fadok VA, Bratton DL, Worthen GS, Henson PM. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J Biol Chem. 1998;273(14):8389-8397. (Pubitemid 28168900)
36. Hannun YA, Loomis CR, Merrill AH Jr, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem. 1986;261(27):12604-12609. (Pubitemid 17213985)
37. Chang HC, Tsai LH, Chuang LY, Hung WC. Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J Cell Physiol. 2001;188(2):188-193.